Search hospitals
>
California
>
Loma Linda
Loma Linda University Medical Center
Claim this profile
Loma Linda, California 92354
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Brain Tumor
Conducts research for Solid Tumors
Conducts research for Neuroblastoma
449 reported clinical trials
32 medical researchers
Summary
Loma Linda University Medical Center is a medical facility located in Loma Linda, California. This center is recognized for care of Cancer, Lung Cancer, Brain Tumor, Solid Tumors, Neuroblastoma and other specialties. Loma Linda University Medical Center is involved with conducting 449 clinical trials across 936 conditions. There are 32 research doctors associated with this hospital, such as Albert Kheradpour, Hamid R. Mirshahidi, Mark E. Reeves, and Hisham Abdel-Azim, MD.
Area of expertise
Cancer
Loma Linda University Medical Center has run 58 trials for Cancer. Some of their research focus areas include:
Lung Cancer
Loma Linda University Medical Center has run 47 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Albert Kheradpour
Loma Linda University Medical Center
8 years of reported clinical research
Hamid R. Mirshahidi
Loma Linda University Medical Center
6 years of reported clinical research
Mark E. Reeves
Veterans Affairs Loma Linda Healthcare System
12 years of reported clinical research
Hisham Abdel-Azim, MD
Children's Hospital of Los Angeles
7 years of reported clinical research
Clinical Trials running at Loma Linda University Medical Center
Lung Cancer
Breast Cancer
Brain Tumor
Breast cancer
Cancer
Wilms Tumor
Testicular cancer
Neuroblastoma
Burkitt Lymphoma
Leukemia
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting
2 awards
Phase 3
7 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Immunotherapy Combinations
for Lung Cancer
This is a Phase 1b/2 study evaluating the anti-PD1 antibody, cemiplimab, in combination with either S095018 (anti-TIM3 antibody), S095024 (anti-CD73 antibody), or S095029 (anti-NKG2A antibody) in adult participants with previously untreated advanced/metastatic non-small cell lung cancer (NSCLC) with high PD-L1 expression. The study includes two parts: part A, the combination-therapy safety lead-in phase to determine the recommended dose for expansion (RDE) for S095018, S095024, and S095029 in combination with cemiplimab and part B, the randomized dose expansion phase to assess the efficacy of S095018, S095024, or S095029 in combination with cemiplimab. Study treatment will be administered for a maximum of 108 weeks, or until confirmed disease progression per iRECIST and/ or until meeting other treatment discontinuation criteria.
Recruiting
1 award
Phase 1 & 2
5 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Loma Linda University Medical Center?
Loma Linda University Medical Center is a medical facility located in Loma Linda, California. This center is recognized for care of Cancer, Lung Cancer, Brain Tumor, Solid Tumors, Neuroblastoma and other specialties. Loma Linda University Medical Center is involved with conducting 449 clinical trials across 936 conditions. There are 32 research doctors associated with this hospital, such as Albert Kheradpour, Hamid R. Mirshahidi, Mark E. Reeves, and Hisham Abdel-Azim, MD.
Where is Loma Linda University Medical Center located?
**Loma Linda University Medical Center** - **Address:** 11234 Anderson St, Loma Linda, CA 92354 - **Directions:** Take the I-10 E to exit 62 for Anderson St in Loma Linda, then turn left onto Anderson St. **Loma Linda University Medical Center-Murrieta** - **Address:** 28062 Baxter Rd, Murrieta, CA 92563 - **Directions:** Head to 28062 Baxter Rd, Murrieta via I-15 N and CA-79 S.
Who should I call to ask about financial aid or insurance network?
**Loma Linda University Medical Center Financial Assistance and Insurance Inquiries:** - For financial assistance, including policies and application processes, contact the billing department at **909-651-4177**. They assist uninsured or underinsured patients with hospital bill concerns. - For insurance-related questions, including billing, patient balances, and claim submissions, call **909-651-4177**. Note: Most physicians and independent healthcare providers will issue separate bills.
What insurance does Loma Linda University Medical Center accept?
Loma Linda University Medical Center accepts a broad spectrum of insurance plans, such as popular HMOs and PPOs, Inland Empire Health Plan (IEHP), Medi-Cal, and Medicare. They are also part of the Blue Shield HMO and PPO networks, ensuring access to their medical centers, urgent cares, and primary care providers. It's advised to verify coverage with your insurance company directly.
What awards or recognition has Loma Linda University Medical Center received?
Loma Linda University Medical Center is renowned for its groundbreaking medical achievements and has been awarded $85 million in extramural awards for research in the last fiscal year. The center is celebrated for milestones including the first infant heart transplant, pioneering the use of a proton accelerator for cancer treatment, and inventing a nerve block technique in dentistry. It boasts prestigious accolades such as Comprehensive Stroke Center Certification, Quality Accredited Cancer Program by the American College of Surgeons, and Magnet Recognition for excellence in nursing.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.